This is little more than a side show. The elephant in the room is still our fractured relationship with GSPC and until this is resolved Cambay will remain a pipe dream.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025